Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 267

    1.

    What is the best predictor of future type 2 diabetes?

    Abdul-Ghani MA, Williams K, DeFronzo RA, Stern M.

    Diabetes Care. 2007 Jun;30(6):1544-8. Epub 2007 Mar 23.PMID: 17384342 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Risk of progression to type 2 diabetes based on relationship between postload plasma glucose and fasting plasma glucose.

    Abdul-Ghani MA, Williams K, DeFronzo R, Stern M.

    Diabetes Care. 2006 Jul;29(7):1613-8.PMID: 16801587 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    The homeostasis model in the San Antonio Heart Study.

    Haffner SM, Miettinen H, Stern MP.

    Diabetes Care. 1997 Jul;20(7):1087-92.PMID: 9203442 [PubMed - indexed for MEDLINE]Related articles

    4.

    Fasting versus postload plasma glucose concentration and the risk for future type 2 diabetes: results from the Botnia Study.

    Abdul-Ghani MA, Lyssenko V, Tuomi T, DeFronzo RA, Groop L.

    Diabetes Care. 2009 Feb;32(2):281-6. Epub 2008 Nov 18.PMID: 19017778 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    One-hour plasma glucose concentration and the metabolic syndrome identify subjects at high risk for future type 2 diabetes.

    Abdul-Ghani MA, Abdul-Ghani T, Ali N, Defronzo RA.

    Diabetes Care. 2008 Aug;31(8):1650-5. Epub 2008 May 16.PMID: 18487478 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Prediction of type 2 diabetes using simple measures of insulin resistance: combined results from the San Antonio Heart Study, the Mexico City Diabetes Study, and the Insulin Resistance Atherosclerosis Study.

    Hanley AJ, Williams K, Gonzalez C, D'Agostino RB Jr, Wagenknecht LE, Stern MP, Haffner SM; San Antonio Heart Study; Mexico City Diabetes Study; Insulin Resistance Atherosclerosis Study.

    Diabetes. 2003 Feb;52(2):463-9. Erratum in: Diabetes. 2003 May;52(5):1306. PMID: 12540622 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Predicting future cardiovascular disease: do we need the oral glucose tolerance test?

    Stern MP, Fatehi P, Williams K, Haffner SM.

    Diabetes Care. 2002 Oct;25(10):1851-6.PMID: 12351490 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Comparison of a clinical model, the oral glucose tolerance test, and fasting glucose for prediction of type 2 diabetes risk in Japanese Americans.

    McNeely MJ, Boyko EJ, Leonetti DL, Kahn SE, Fujimoto WY.

    Diabetes Care. 2003 Mar;26(3):758-63.PMID: 12610034 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Identification of persons at high risk for type 2 diabetes mellitus: do we need the oral glucose tolerance test?

    Stern MP, Williams K, Haffner SM.

    Ann Intern Med. 2002 Apr 16;136(8):575-81.PMID: 11955025 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Risk assessment by post-challenge plasma glucose, insulin response ratio, and other indices of insulin resistance and/or secretion for predicting the development of type 2 diabetes.

    Tanabe N, Saito K, Yamada Y, Takasawa T, Seki N, Suzuki H.

    Intern Med. 2009;48(6):401-9. Epub 2009 Mar 16.PMID: 19293537 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Beta-cell dysfunction and glucose intolerance: results from the San Antonio metabolism (SAM) study.

    Gastaldelli A, Ferrannini E, Miyazaki Y, Matsuda M, DeFronzo RA; San Antonio metabolism study.

    Diabetologia. 2004 Jan;47(1):31-9. Epub 2003 Dec 10.PMID: 14666364 [PubMed - indexed for MEDLINE]Related articles

    13.

    Risk of future diabetes is as high with abnormal intermediate post-glucose response as with impaired glucose tolerance.

    Viswanathan V, Clementina M, Nair BM, Satyavani K.

    J Assoc Physicians India. 2007 Dec;55:833-7.PMID: 18405128 [PubMed - indexed for MEDLINE]Related articles

    14.

    Nondiabetic Mexican-Americans do not have reduced insulin responses relative to nondiabetic non-Hispanic whites.

    Haffner SM, Miettinen H, Stern MP.

    Diabetes Care. 1996 Jan;19(1):67-9.PMID: 8720538 [PubMed - indexed for MEDLINE]Related articles

    15.

    The metabolic syndrome as predictor of type 2 diabetes: the San Antonio heart study.

    Lorenzo C, Okoloise M, Williams K, Stern MP, Haffner SM; San Antonio Heart Study.

    Diabetes Care. 2003 Nov;26(11):3153-9.PMID: 14578254 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Hyperbolic relationship between insulin secretion and sensitivity on oral glucose tolerance test.

    Retnakaran R, Shen S, Hanley AJ, Vuksan V, Hamilton JK, Zinman B.

    Obesity (Silver Spring). 2008 Aug;16(8):1901-7. Epub 2008 Jun 12.PMID: 18551118 [PubMed - indexed for MEDLINE]Related articles

    18.

    Visceral adiposity and risk of type 2 diabetes: a prospective study among Japanese Americans.

    Boyko EJ, Fujimoto WY, Leonetti DL, Newell-Morris L.

    Diabetes Care. 2000 Apr;23(4):465-71.PMID: 10857936 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Absence of an acute insulin response predicts onset of type 2 diabetes in a Caucasian population with impaired glucose tolerance.

    Nijpels G, Boorsma W, Dekker JM, Hoeksema F, Kostense PJ, Bouter LM, Heine RJ.

    J Clin Endocrinol Metab. 2008 Jul;93(7):2633-8. Epub 2008 May 6.PMID: 18460558 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Insulin secretion and resistance in nondiabetic Mexican Americans and non-Hispanic whites with a parental history of diabetes.

    Haffner SM, Miettinen H, Stern MP.

    J Clin Endocrinol Metab. 1996 May;81(5):1846-51.PMID: 8626845 [PubMed - indexed for MEDLINE]Related articles